Vinita Dhir Tandon, MD
Endocrinology, Diabetes & Metabolism · Mountain View
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Tandon’s office at (650) 967-8841 to ask if they take your plan before you enroll.
California Medical Board record
Licence A79669 · Current
Licensed to practise in California · since 2002 · expires 2028-07-31 · Boston University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism
Drugs they prescribed that Part D paid
$6,360
Pharmacies billed $6,360 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 15) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
$6,360 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 15 | None | 0% (0) | None | $6,360 |
| 2022 | 31 | 12 | 0% (0) | None | $2,929 |
| 2021 | 107 | 25 | 0% (0) | None | $10,024 |
| 2020 | 150 | 29 | 0% (0) | None | $11,897 |
| 2019 | 178 | 39 | 0% (0) | 15% | $12,658 |
| 2018 | 223 | 55 | 0% (0) | 22% | $45,554 |
| 2017 | 620 | 84 | 0% (0) | 40% | $167,128 |
| 2016 | 790 | 80 | 0% (0) | 39% | $129,680 |
| 2015 | 883 | 85 | 1% (12) | 44% | $181,641 |
| 2014 | 964 | 90 | None | 44% | $164,185 |
| 2013 | 1,060 | 97 | 0% (0) | 41% | $152,015 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 1 drug
| Progesterone | 14 | $1,810 | $129 |
2021: 4 drugs
| Progesterone | 42 | $5,642 | $134 |
| Armour Thyroid | 14 | $1,086 | $78 |
| Spironolactone | 20 | $371 | $19 |
| Estradiol | 12 | $225 | $19 |
2020: 4 drugs
| Progesterone | 72 | $6,134 | $85 |
| Estradiol (Twice Weekly) | 14 | $1,243 | $89 |
| Spironolactone | 17 | $329 | $19 |
| Estradiol | 23 | $252 | $11 |
2019: 5 drugs
| Progesterone | 67 | $4,292 | $64 |
| Estradiol | 28 | $2,675 | $96 |
| NP Thyroid | 24 | $1,078 | $45 |
| Armour Thyroid | 22 | $894 | $41 |
| Spironolactone | 15 | $306 | $20 |
2018: 3 drugs
| Progesterone | 77 | $3,786 | $49 |
| NP Thyroid | 13 | $491 | $38 |
| Levothyroxine | 20 | $434 | $22 |
2017: 12 drugs
| Lantus Solostar | 18 | $7,593 | $422 |
| Levothyroxine | 119 | $3,033 | $25 |
| Tirosint | 15 | $2,773 | $185 |
| Synthroid | 39 | $2,176 | $56 |
| Ultra-Fine Short Pen Needle | 16 | $929 | $58 |
| Metformin | 32 | $450 | $14 |
| Fenofibrate | 11 | $344 | $31 |
| Montelukast | 12 | $168 | $14 |
| Lisinopril | 12 | $100 | $8 |
| Metformin Hcl Er | 12 | $99 | $8 |
| Hydrochlorothiazide | 21 | $90 | $4 |
| Simvastatin | 14 | $60 | $4 |
2016: 22 drugs
| Lantus Solostar | 21 | $14,219 | $677 |
| Januvia | 19 | $11,268 | $593 |
| Humalog Kwikpen U-100 | 12 | $10,936 | $911 |
| Levemir Flextouch | 16 | $9,579 | $599 |
| Crestor | 19 | $8,700 | $458 |
| Janumet | 11 | $7,230 | $657 |
| Bd Ultra-Fine Pen Needle | 48 | $3,418 | $71 |
| Levothyroxine | 153 | $3,376 | $22 |
| Synthroid | 66 | $2,792 | $42 |
| Eplerenone | 15 | $1,770 | $118 |
| Metformin | 57 | $745 | $13 |
| Fenofibrate | 11 | $727 | $66 |
| Gabapentin | 11 | $313 | $28 |
| Ramipril | 20 | $263 | $13 |
| Lisinopril | 19 | $259 | $14 |
| Metformin Hcl Er | 20 | $234 | $12 |
| Hydrochlorothiazide | 28 | $175 | $6 |
| Simvastatin | 17 | $157 | $9 |
| Atenolol | 16 | $139 | $9 |
| Losartan | 13 | $106 | $8 |
| Glimepiride | 14 | $104 | $7 |
| Amlodipine Besylate | 11 | $93 | $8 |
2015: 21 drugs
| Lantus Solostar | 45 | $34,463 | $766 |
| Levemir Flextouch | 19 | $17,649 | $929 |
| Januvia | 27 | $15,221 | $564 |
| Levemir | 12 | $13,338 | $1,111 |
| Humalog Kwikpen U-100 | 19 | $11,316 | $596 |
| Crestor | 27 | $11,253 | $417 |
| Novolog Flexpen | 13 | $7,619 | $586 |
| Levothyroxine | 174 | $4,056 | $23 |
| Bd Ultra-Fine Pen Needle | 54 | $3,773 | $70 |
| Synthroid | 52 | $2,696 | $52 |
| Tirosint | 11 | $1,326 | $121 |
| Metformin | 77 | $1,100 | $14 |
| Glipizide Xl | 13 | $495 | $38 |
| Ramipril | 22 | $268 | $12 |
| Lisinopril | 25 | $250 | $10 |
| Gabapentin | 19 | $212 | $11 |
| Hydrocodone-Acetaminophen | 12 | $210 | $17 |
| Simvastatin | 15 | $132 | $9 |
| Glipizide | 11 | $99 | $9 |
| Hydrochlorothiazide | 13 | $96 | $7 |
| Clonidine | 11 | $62 | $6 |
2014: 22 drugs
| Lantus Solostar | 40 | $21,829 | $546 |
| Crestor | 49 | $13,522 | $276 |
| Januvia | 22 | $11,311 | $514 |
| Levemir | 11 | $8,571 | $779 |
| Humalog | 11 | $5,359 | $487 |
| Bydureon | 11 | $4,882 | $444 |
| Levothyroxine | 146 | $3,223 | $22 |
| Synthroid | 77 | $3,112 | $40 |
| Bd Ultra-Fine Pen Needle | 51 | $2,520 | $49 |
| Metformin | 90 | $1,330 | $15 |
| Glipizide Er | 17 | $840 | $49 |
| Pravastatin | 16 | $637 | $40 |
| Glipizide Xl | 11 | $544 | $49 |
| Glyburide | 14 | $384 | $27 |
| Lisinopril | 25 | $303 | $12 |
| Simvastatin | 21 | $245 | $12 |
| Ramipril | 13 | $207 | $16 |
| Atenolol | 14 | $193 | $14 |
| Gabapentin | 15 | $135 | $9 |
| Glipizide | 18 | $133 | $7 |
| Clonidine | 11 | $84 | $8 |
| Hydrochlorothiazide | 18 | $81 | $4 |
2013: 28 drugs
| Lantus Solostar | 45 | $21,322 | $474 |
| Victoza 3-Pak | 20 | $18,299 | $915 |
| Crestor | 24 | $8,226 | $343 |
| Novolog Flexpen | 17 | $6,834 | $402 |
| Androgel | 13 | $6,409 | $493 |
| Januvia | 14 | $6,375 | $455 |
| Levemir Flexpen | 14 | $5,780 | $413 |
| Bydureon | 12 | $4,497 | $375 |
| Humalog | 16 | $3,765 | $235 |
| Zetia | 16 | $3,222 | $201 |
| Synthroid | 71 | $2,776 | $39 |
| Bd Ultra-Fine Pen Needle | 55 | $2,319 | $42 |
| Levothyroxine | 150 | $2,058 | $14 |
| Metformin | 103 | $1,669 | $16 |
| Glipizide Xl | 21 | $753 | $36 |
| Glyburide | 17 | $591 | $35 |
| Insulin | 19 | $537 | $28 |
| Glipizide Er | 11 | $524 | $48 |
| Simvastatin | 28 | $435 | $16 |
| Gabapentin | 28 | $399 | $14 |
| Pravastatin | 14 | $385 | $27 |
| Glipizide | 26 | $335 | $13 |
| Lisinopril | 25 | $287 | $11 |
| Alendronate | 13 | $206 | $16 |
| Atenolol | 11 | $162 | $15 |
| Amlodipine Besylate | 14 | $113 | $8 |
| Triamterene-Hctz | 13 | $105 | $8 |
| Hydrochlorothiazide | 12 | $71 | $6 |
Money from drug and device companies
$18 in 2025
| 2025 | 1 | 1 | None | $18 |
| 2019 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Heartflow | Ffrct | $18 | 1 payment
|
See the published payment
| Heartflow | Meals · 2025-07-28 | Ffrct | $18 |
See earlier years (2019)
2019: $125
| Neurocrine Biosciences | Ingrezza | $125 | 1 payment
|
Professional record
- NPI
- 1124105481
- Licence
- CA A79669California A79669: Current · expires 2028-07-31
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 2204 Grant Rd, Suite 103, Mountain View, CA, 94040
- NPI first listed
- 2006-11-01
- NPI last updated
- 2011-05-24
This is when the NPI record was last certified, not a medical board exam.